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To the Editor: Infections with typhus group rickettsiae 
(TGR), spotted fever group rickettsiae (SFGR), and scrub 
typhus group orientiae (STGO) have been reported among 
persons in South Korea in increasing numbers over the past 
decade (1,2). During 2001–2011 in South Korea, 51,825 ori-
entiae group infections were reported (mean incidence 9.95 
cases/100,000 residents/year) (2). TGR (Rickettsia typhi), 
SFGR (R. akari, R. japonica, R. monacensis, and R. felis), 
and STGO (Orientia tsutsugamusi) have been identified in 
their arthropod vectors and reservoirs in northern provinces 
and at US military training facilities in South Korea (3–5).
Currently, little data exist on the risk for rickettsioses 
and scrub typhus for US military deployed to South Korea. 
Thus, a retrospective serologic investigation to determine 
the level of exposure to rickettsiae among 9,303 military 
personnel deployed to South Korea was conducted. The 
study used de-identified predeployment and postdeploy-
ment serum samples made available from the Department 
of Defense Serum Repository (6). The study group con-
sisted of men in combat-related jobs at US military training 
sites and military installations in South Korea during 1990–
1995 while on active duty continuously for >1 year. This 
study protocol was reviewed and approved by the Naval 
Medical Research Command Institutional Review Board in 
compliance with all applicable federal regulations govern-
ing the protection of human subjects. 
Age range of the 9,303 soldiers in the study group 
was 17–52 (median 24) years. Most (99.6%) were sta-
tioned in Dongducheon, Yongtaeri, and Seoul, located in 
the Gyeonggi and Gangwon provinces in northern South 
Korea. Primary military occupation specialties were in-
fantryman (58.8%), fighting vehicle infantryman (22.4%), 
indirect fire infantryman (12.3%), and heavy anti-armor 
weapons infantryman (6.5%).
The soldiers’ postdeployment serum samples (n = 
9,303) were screened at a dilution of 1:100 for IgG against 
TGR, SFGR, and STGO by using group-specific ELISA 
whole-cell antigen preparations from R. typhi Wilmington, 
R. conorii Morrocan, and a mixture of O. tsutsugamushi 
Karp, Kato, and Gilliam, respectively (7,8). TGR, SFGR, 
and STGO IgG ELISA titers (range 100–>6,400) were 
determined for screen-positive (net absorbance >0.500) 
postdeployment serum samples, and results were compared 
with matched predeployment serum samples. Samples with 
a net total absorbance >1.000 for serum dilutions 1:100, 
1:400, 1:1,600, and 1:6,400 were considered titer positive. 
The inverse of the highest dilution of titer positive serum 
that produced a net absorbance >0.200 was determined to 
be the titer. Serum samples from laboratory animals infect-
ed with R. felis reacted specifically in the SFGR ELISA but 
not in the TGR ELISA (K.R. Macaluso and A.L. Richards, 
unpub. data); thus, any soldier infected with R. felis would 
have reacted in the SFGR but not the TGR ELISA.
The postdeployment seropositivity in US military per-
sonnel for antibodies against TGR, SFGR, and STGO at a 
titer ≥100 were 1.3% (117/9,249), 9.0% (805/8,918), and 
0.5% (44/9,135), respectively (Figure). Seropositivity oc-
curred for 10 (0.1%), 181 (2.0%), and 15 (0.2%) men who 
showed evidence of infection (seroconversion or 4-fold rise 
in antibody titer) with TGR, SFGR, and STGO, respective-
ly, during their deployment to South Korea (Figure). The 
chance of a soldier having an infection with SFGR was 
significantly higher than the chance of having an infection 
with TGR or STGO (χ2 test, p<0.05) (analysis performed 
in SAS version 9.4; SAS Institute Inc., Cary, NC, USA). 
For personnel who seroconverted or had a 4-fold rise in 
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Figure. Evidence of rickettsiosis or scrub typhus among US 
military personnel deployed to South Korea. Black bars indicate 
postdeployment serum samples from US military personnel with 
a titer ≥1:100 (seropositive) to typhus group rickettsiae (TGR), 
spotted fever group rickettsiae (SFGR), or scrub typhus group 
orientia (STGO) IgG, as determined by ELISA. White bars indicate 
personnel determined by paired serum sample analyses to have 
seroconversion or 4-fold rise in titer between predeployment and 
postdeployment serum samples, indicating evidence of infection 
with the corresponding pathogen during deployment.
titer to TGR, SFGR, or STGO, the age range was 19–49 
(median 25) years, and job specialties were infantrymen 
(63.5%), fighting vehicle infantrymen (16.4%), indirect 
fire infantrymen (14.2%), and heavy anti-armor weapons 
infantrymen (5.9%).
These results indicate that many US military person-
nel were exposed to rickettsiae and orientiae before their 
deployment to South Korea (Figure), perhaps because of 
previous deployments around the world or because of ex-
posure to rickettsial agents at home (8–10). However, 206 
(2.2%) of the men became infected with either a typhus 
group (n = 10) or spotted fever group (n = 181) rickettsia or 
a scrub typhus group orientia (n = 15) during their deploy-
ment to South Korea.
More SFGR infections occurred than TGR and STGO 
infections, although the pathogens for the latter infections 
(R. typhi and O. tsutsugamushi) are considered endemic 
to South Korea and are believed to affect the public and 
military health more than SFGR (3). The SFGR infec-
tions might correlate with recent observations of highly 
prevalent rickettsia-infected tick and R. felis–infected flea 
populations seen in South Korea (4,5). No evidence of 
co-infection was found in the men assessed during the 
deployment. These results suggest a risk for rickettsial 
disease, including scrub typhus and especially spotted fe-
ver, among US military personnel stationed in or visiting 
South Korea.
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To the Editor: Control of methicillin-resistant Staphy-
lococcus aureus (MRSA) is an international public health 
priority. The Netherlands is among countries in Europe that 
have a low prevalence of MRSA among humans, largely 
because of a national search and destroy policy (1). The 
overall prevalence in long-term care facilities (LTCFs) is 
low (2). However, this policy is challenged by an increase 
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